MAA
WINT

Managed Account Advisors’s Windtree Therapeutics Inc WINT Stock Holding History

Managed Account Advisors’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-573
Closed -$17K – 2696
2014
Q1 		$17K Sell
573
-505
-47% -$17K ﹤0.01% 2495
2013
Q4 		$34K Sell
1,078
-884
-45% -$27.6K ﹤0.01% 2398
2013
Q3 		$54K Sell
1,962
-152
-7% -$3.68K ﹤0.01% 2277
2013
Q2 		$45K Buy
+2,114
New +$52.1K ﹤0.01% 2291

Other funds holding WINT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Managed Account Advisors's WINT Position: Q2 2014 in Review

Managed Account Advisors sold out of Windtree Therapeutics Inc (WINT) in Q2 2014, closing a stake of 573 shares — an estimated $17K sold.

Managed Account Advisors first reported a position in WINT in Q2 2013 and held it in 4 quarters. The position peaked at $54K in Q3 2013. 67 funds tracked by Wall St. Rank hold WINT as of Q2 2014.

  • Managed Account Advisors reported no remaining Windtree Therapeutics Inc position as of Q2 2014 after selling out during the quarter.
  • Managed Account Advisors sold 573 Windtree Therapeutics Inc shares in Q2 2014, an estimated $17K.
  • Managed Account Advisors first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 4 quarters.
  • Managed Account Advisors's Windtree Therapeutics Inc position peaked at $54K in Q3 2013.
  • 67 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2014.

Based on Managed Account Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.